Literature DB >> 21037908

Personalized medicine: part 1: evolution and development into theranostics.

F Randy Vogenberg, Carol Isaacson Barash, Michael Pursel.   

Abstract

Keywords:  gene testing; human genome; personal genomics; personalized medicine; pharmacodiagnostics; pharmacogenetics; pharmacogenomics; theranostics

Year:  2010        PMID： 21037908      PMCID： PMC2957753     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  1 in total

Review 1.  Pharmacogenomics: the promise of personalized medicine.

Authors:  L Mancinelli; M Cronin; W Sadée
Journal:  AAPS PharmSci       Date:  2000
  1 in total
  57 in total

1.  Pharmacogenomics in clinical practice: reality and expectations.

Authors:  C Lee Ventola
Journal:  P T       Date:  2011-07

2.  Theranostics: is it really a revolution? Evaluating a new term in medicine.

Authors:  Urban Wiesing
Journal:  Med Health Care Philos       Date:  2019-12

3.  State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach.

Authors:  Elliot B Levy; Maria I Fiel; Stanley R Hamilton; David E Kleiner; Shannon J McCall; Peter Schirmacher; William Travis; Michael D Kuo; Robert D Suh; Alda L Tam; Shaheen U Islam; Katherine Ferry-Galow; Rebecca A Enos; James H Doroshow; Hala R Makhlouf
Journal:  J Clin Oncol       Date:  2020-03-05       Impact factor: 44.544

4.  GATA1 gets personal.

Authors:  Anna Rita Migliaccio
Journal:  Haematologica       Date:  2020-04       Impact factor: 9.941

5.  Personalized medicine could transform healthcare.

Authors:  Sunil Mathur; Joseph Sutton
Journal:  Biomed Rep       Date:  2017-06-02

Review 6.  Norwegian drug information centres strongly promote person-centred and personalised medicine: a brief report on the achievements and strategy.

Authors:  Jan Schjøtt
Journal:  EPMA J       Date:  2019-04-30       Impact factor: 6.543

7.  Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions.

Authors:  Daniel G Stover; Raquel E Reinbolt; Elizabeth J Adams; Sarah Asad; Katlyn Tolliver; Mahmoud Abdel-Rasoul; Cynthia D Timmers; Susan Gillespie; James L Chen; Siraj Mahamed Ali; Katharine A Collier; Mathew A Cherian; Anne M Noonan; Sagar Sardesai; Jeffrey VanDeusen; Robert Wesolowski; Nicole Williams; Clara N Lee; Charles L Shapiro; Erin R Macrae; Bhuvaneswari Ramaswamy; Maryam B Lustberg
Journal:  JCO Precis Oncol       Date:  2019-11-18

8.  Genetics of personalized medicine: cancer and rare diseases.

Authors:  Inês Teles Siefers Alves; Manuel Condinho; Sónia Custódio; Bruna F Pereira; Rafael Fernandes; Vânia Gonçalves; Paulo J da Costa; Rafaela Lacerda; Ana Rita Marques; Patrícia Martins-Dias; Gonçalo R Nogueira; Ana Rita Neves; Patrícia Pinho; Raquel Rodrigues; Eva Rolo; Joana Silva; André Travessa; Rosário Pinto Leite; Ana Sousa; Luísa Romão
Journal:  Cell Oncol (Dordr)       Date:  2018-04-09       Impact factor: 6.730

Review 9.  Nanotheranostics for personalized medicine.

Authors:  Tae Hyung Kim; Seulki Lee; Xiaoyuan Chen
Journal:  Expert Rev Mol Diagn       Date:  2013-04       Impact factor: 5.225

Review 10.  Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope.

Authors:  Atif Zafar; Wei Wang; Gang Liu; Wa Xian; Frank McKeon; Jia Zhou; Ruiwen Zhang
Journal:  Cancer Lett       Date:  2020-09-29       Impact factor: 8.679
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.